Manav Teli, Director, Lord’s Mark Industries is a business strategist and innovative administrator, with over 30+years’ experience in leading a business and entrepreneurial ventures. In an exclusive interview, Manav explains his company’s collaboration with Hindustan Antibiotics Limited besides its latest initiatives and outlook:
What are the key milestones achieved by LordsMed and its long-term goals?
LordsMed has achieved several milestones in its journey toward promoting good health and well-being. We have developed and launched over 50 registered brands under the Diagnostic vertical, including the ICMR-approved LordsMed rapid antigen kit. Our Hygiene Care vertical has two umbrella brands, SafeSehat and MarkoSafe, which aim to promote hygiene and prevent the spread of infections. We have also launched Safelite, our own brand of sanitary napkins, to promote menstrual health and hygiene among women. Our efforts are aligned with the sustainable development goal (SDG)-3 of the United Nations, which aims to ensure healthy lives and promote well-being for all.
Our long-term goals are focused on expanding our reach to more geographies, investing in R&D to develop innovative healthcare solutions, increasing our focus on preventive healthcare, and collaborating with other organizations and stakeholders to address key healthcare challenges. By achieving these goals, we aim to make our products and services accessible to a larger population, improve the quality of life of people, and contribute towards a healthier and happier world.
LordsMed has collaborated with Sensing Self to launch a 99% accuracy rate saliva-based rapid antigen test kit. What long-term benefits of this initiative and response so far?
The collaboration between LordsMed and Sensing Self to launch a 99% accuracy rate saliva-based rapid antigen test kit has several long-term benefits. Firstly, it provides a convenient and reliable way of testing for COVID-19 using saliva samples, which is less invasive and more comfortable for patients. This can help increase testing capacity and accessibility, particularly in remote areas or regions where there is a shortage of testing facilities. Secondly, the high accuracy rate of the test kit can facilitate early diagnosis and treatment of COVID-19, which can help reduce the spread of the virus and prevent further transmission. Early detection can also improve patient outcomes and reduce the burden on healthcare systems. Thirdly, the initiative can have a positive impact on public health, as it can help contain the spread of the virus and mitigate the effects of the pandemic.
“Some of the key factors that affect the business environment are the global pandemic, digital transformation, environmental and social issues, and geopolitical tensions.”